REVA Medical, Inc.·4

Sep 22, 8:44 PM ET

REVA Medical, Inc. 4

4 · REVA Medical, Inc. · Filed Sep 22, 2015

Insider Transaction Report

Form 4
Period: 2015-09-18
Brandom Donald K.
VP, Biomaterials Product Dev
Transactions
  • Sale

    Common Stock

    2015-09-18$4.28/sh200$85591,212.8 total
  • Sale

    Common Stock

    2015-09-21$4.37/sh3,662.8$16,01785,050 total
  • Sale

    Common Stock

    2015-09-21$4.45/sh2,500$11,11388,712.8 total
Footnotes (4)
  • [F1]The sale was executed in the form of CDIs, trading on the Austrialian Securities Exchange, and as such the sale price has been converted to a USD equivalent, adjusting for the ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.
  • [F2]Represents the sale of 2,000 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.
  • [F3]Represents the sale of 25,000 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.
  • [F4]Represents the sale of 36,628 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION